Literature DB >> 21087109

Respective roles of TLR, RIG-I and NLRP3 in influenza virus infection and immunity: impact on vaccine design.

Takeshi Ichinohe1.   

Abstract

Influenza A virus is the etiological agent of a highly contagious acute respiratory disease that causes epidemics and considerable mortality annually. It has become increasingly evident that influenza viral infection is recognized by at least three classes of pattern-recognition receptors, including TLR-7, the retinoic acid inducible gene-I and nucleotide-binding domain and leucine-rich-repeat-containing protein 3, a member of the Nod-like receptor family. This article highlights the roles of different types of innate immune receptors in influenza virus immunity versus immunopathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087109     DOI: 10.1586/erv.10.118

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  23 in total

1.  Long-term antibody and immune memory response induced by pulmonary delivery of the influenza Iscomatrix vaccine.

Authors:  Ana Vujanic; Kenneth J Snibson; Janet L K Wee; Stirling J Edwards; Martin J Pearse; Jean-Pierre Y Scheerlinck; Philip Sutton
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

2.  The RNA- and TRIM25-Binding Domains of Influenza Virus NS1 Protein Are Essential for Suppression of NLRP3 Inflammasome-Mediated Interleukin-1β Secretion.

Authors:  Miyu Moriyama; I-Yin Chen; Atsushi Kawaguchi; Takumi Koshiba; Kyosuke Nagata; Haruko Takeyama; Hideki Hasegawa; Takeshi Ichinohe
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

3.  IL-36γ Protects against Severe Influenza Infection by Promoting Lung Alveolar Macrophage Survival and Limiting Viral Replication.

Authors:  Alexander N Wein; Paul R Dunbar; Sean R McMaster; Zheng-Rong Tiger Li; Timothy L Denning; Jacob E Kohlmeier
Journal:  J Immunol       Date:  2018-05-30       Impact factor: 5.422

Review 4.  Autophagy and selective deployment of Atg proteins in antiviral defense.

Authors:  Brian Yordy; Michal Caspi Tal; Kachiko Hayashi; Omotooke Arojo; Akiko Iwasaki
Journal:  Int Immunol       Date:  2012-10-05       Impact factor: 4.823

5.  Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.

Authors:  Yufeng Song; Xiang Wang; Hongbo Zhang; Xinying Tang; Min Li; Jufang Yao; Xia Jin; Hildegund C J Ertl; Dongming Zhou
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

6.  The role of MyD88 signaling in heterosubtypic influenza A virus infections.

Authors:  Rachel F Madera; Daniel H Libraty
Journal:  Virus Res       Date:  2012-12-10       Impact factor: 3.303

Review 7.  Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.

Authors:  Fatma Berri; Vuong Ba Lê; Martine Jandrot-Perrus; Bruno Lina; Béatrice Riteau
Journal:  Cell Mol Life Sci       Date:  2013-10-04       Impact factor: 9.261

8.  Inactivated vaccine with adjuvants consisting of pattern recognition receptor agonists confers protection against avian influenza viruses in chickens.

Authors:  Yinghua Tang; Jihu Lu; Peipei Wu; Zhenxing Liu; Zhen Tian; Guofei Zha; Hui Chen; Qiaochu Wang; Qiaoxiu Wang; Fengxiang Hou; Sang-Moo Kang; Jibo Hou
Journal:  Vet Microbiol       Date:  2014-05-13       Impact factor: 3.293

Review 9.  The personal touch: strategies toward personalized vaccines and predicting immune responses to them.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Lambert; Iana H Haralambieva; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2014-04-04       Impact factor: 5.217

10.  Role of tissue protection in lethal respiratory viral-bacterial coinfection.

Authors:  Amanda M Jamieson; Lesley Pasman; Shuang Yu; Pia Gamradt; Robert J Homer; Thomas Decker; Ruslan Medzhitov
Journal:  Science       Date:  2013-04-25       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.